Our Team

 
Anven Rusty Williams.png

Lewis T. "Rusty" Williams | MD, PhD

Co-Founder, Executive Chairman

  • Founder and Chairman of Five Prime Therapeutics. Founder of COR Therapeutics. 

  • Chief Scientific Officer & board member , Chiron Corporation (now Novartis Vaccines and Diagnostics, Inc.),

  • Professor of medicine, UCSF and director of Cardiovascular Research Institution and Daiichi Research Center.

  • Member of National Academy of Sciences and fellow of the American Academy of Arts and Sciences.

  • B.S. Rice University; M.D./Ph.D. Duke University.

 
Anven Reddy Moola.png

Reddy Moola | PHD

CEO, Co-Founder, and Board Director

  • PhD from Indian Institute of Chemical Technology with Dr. J.S Yadav. 

  • Faculty at UT Southwestern Medical Center, Dallas and The Scripps Research Institute.

  • Published and patented > 50 novel small molecule and  peptoid-based technologies.

  • Inventor of the Anven’s core technology platform.

 
Anven Bill Shelander.png

Bill Shelander | MSE, MBA

COO, Co-Founder, and Board Director

  • MBA from Stanford University; MS in Chemical Engineering

  • 30+ years of VC management and start ups in advanced technologies

  • Commercialization expert at Lawrence Berkeley National Lab

  • Faculty of Stanford University and Haas School of Business, UC Berkeley

 
Anven Roger Wong.png

Roger Wong | Phd, MBA

SVP, Research and Development

  • PhD in biochemistry, UC Berkeley; MBA at Hough business school at UF.

  • Faculty member directing and publishing publicly funded research projects.

  • Expert in metabolic disease, insulin signaling, cancer, immunology, neurodegenerative disease

  • Seasoned scientist in biotech , diagnostic and pharmaceutical sectors

 

Ronald Zuckermann | PhD

Co-Founder, Board Director, and Member SAB

  • PhD from UC Berkeley in Bioorganic Chemistry with Dr. Peter Schultz; published >160 papers, 38 patents.

  • Director of Biological Nanostructures, Lawrence Berkeley National Lab    http://www.ronznet.com

  • Invented class of heteropolymers called "Peptoids“ in early 1990’s.

  • A founding chemist at Protos Corp. (drug discovery venture)